As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...
Explore cancer drug resistance and its significant impact on treatment options and patient outcomes in modern cancer therapy.
Completed target enrollment in Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the first ...
Materials inspired by nature, or biomimetic materials, are nothing new. Scientists have designed water-resistant materials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results